Diabetes-induced neuroinflammation and neurodegeneration in brain areas involved in pain processing: the role of glucagon-like peptide 1.

Diabetes-induced neuroinflammation and neurodegeneration in brain areas involved in pain processing: the role of glucagon-like peptide 1.

Show other versions (1)

Bibliographic Details
Main Author:	José Tiago da Costa Pereira
Language:	English
Published:	2014
Online Access:	http://hdl.handle.net/10216/77358

Similar Items

Diabetes-induced neuroinflammation and neurodegeneration in brain areas involved in pain processing: the role of glucagon-like peptide 1.
by: José Tiago da Costa Pereira
Published: (2019)

Protective potential of glucagon like peptide 2 (GLP-2) against the neurodegeneration
by: Antonella Amato, et al.
Published: (2019-01-01)

The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain
by: Choon Sang Bae, et al.
Published: (2017-11-01)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017-03-01)

Glucagon-like peptide-1 and glucagon-like peptide-1 analogs nanotechnology-based systems for prevention and therapy of diabetes
by: Ana Francisca Lopes Correia de Araújo
Published: (2019)

Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function
by: Young-Kook Kim, et al.
Published: (2020-08-01)

Glucagon-Like Peptide-1
by: Joel P. Giblett, BM, BSc, et al.
Published: (2016-06-01)

Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain
by: Geeta Ramesh, et al.
Published: (2013-01-01)

Beneficial Effects of Glucagon-Like Peptide-1 (GLP-1) in Diabetes-Induced Retinal Abnormalities: Involvement of Oxidative Stress
by: Hugo Ramos, et al.
Published: (2020-09-01)

The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes
by: Hadjiyianni, Irene Ioanna
Published: (2010)

The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes
by: Hadjiyianni, Irene Ioanna
Published: (2010)

The regulation mechanism of Glucagon-like peptide-1 in diabetic nephropathy
by: HSU,CHIA-YU, et al.
Published: (2014)

VERSATILITY OF THE COMPLEMENT SYSTEM IN NEUROINFLAMMATION, NEURODEGENERATION AND BRAIN HOMEOSTASIS
by: Franca eOrsini, et al.
Published: (2014-11-01)

Mechanisms of neuroinflammation and inflammatory neurodegeneration in acute brain injury
Published: (2015)

Glucagon-like peptide-2 reduces the obesity-associated inflammation in the brain
by: Domenico Nuzzo, et al.
Published: (2019-01-01)

The Effects of TREM2 deficiency on Traumatic Brain Injury- induced Neuroinflammation and Neurodegeneration
by: Saber, Maha M.
Published: (2016)

Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?
by: Matthias Ploug Larsen, et al.
Published: (2017-01-01)

Glucagon-Like Peptide-1 Depots for the Treatment of Type-2 Diabetes
by: Amiram, Miriam
Published: (2012)

STRUCTURAL AND FUNCTIONAL HETEROGENEITY OF ASTROCYTES IN THE BRAIN: ROLE IN NEURODEGENERATION AND NEUROINFLAMMATION
by: A. V. Morgun, et al.
Published: (2014-10-01)

Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration
by: Duraisamy Kempuraj, et al.
Published: (2017-07-01)

Editorial: Mechanisms of neuroinflammation and inflammatory neurodegeneration in acute brain injury
by: Arthur eLiesz, et al.
Published: (2015-08-01)

Corrigendum: Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis.
by: Franca eOrsini, et al.
Published: (2015-07-01)

Neuroinflammation in Post-Ischemic Neurodegeneration of the Brain: Friend, Foe, or Both?
by: Ryszard Pluta, et al.
Published: (2021-04-01)

Role of MCP-1 and CCR2 in ethanol-induced neuroinflammation and neurodegeneration in the developing brain
by: Kai Zhang, et al.
Published: (2018-07-01)

CD38 in Neurodegeneration and Neuroinflammation
by: Serge Guerreiro, et al.
Published: (2020-02-01)

Lipopolysaccharide-Induced Neuroinflammation as a Bridge to Understand Neurodegeneration
by: Carla Ribeiro Alvares Batista, et al.
Published: (2019-05-01)

Glucagon-like peptide 1 (GLP-1)
by: T.D. Müller, et al.
Published: (2019-12-01)

Glucagon-like peptide-1 analogues: An overview
by: Vishal Gupta
Published: (2013-01-01)

Investigation of the antidiabetic actions and function of insulin, glucagon and glucagon-like peptide 1 secreting cells for transplantation therapy of diabetes
by: Green, Alastair David
Published: (2015)

Glucagon-like peptide 1 improved glycemic control in type 1 diabetes
by: McDonald Thomas J, et al.
Published: (2003-04-01)

Alpha-Linolenic Acid Impedes Cadmium-Induced Oxidative Stress, Neuroinflammation, and Neurodegeneration in Mouse Brain
by: Sayed-Ibrar Alam, et al.
Published: (2021-09-01)

Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain
by: Simon C. Cork, et al.
Published: (2015-10-01)

Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes
by: Nina A. Petunina, et al.
Published: (2018-10-01)

Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
by: Silvano Paternoster, et al.
Published: (2018-10-01)

The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis
by: Panjwani, Naim
Published: (2012)

The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis
by: Panjwani, Naim
Published: (2012)

Equine glucagon-like peptide-1 receptor physiology
by: Murad H. Kheder, et al.
Published: (2018-01-01)

Signalling and regulation of the glucagon-like peptide-1 receptor
by: Lu, Jing
Published: (2014)

Does Glucagon-Like Peptide-1 Have a Role in the Etiopathogenesis of Gestational Diabetes?
by: Mustafa Demirpençe, et al.
Published: (2016-06-01)

Oral Delivery of Pentameric Glucagon-Like Peptide-1 by Recombinant Lactobacillus in Diabetic Rats.
by: Yin Lin, et al.
Published: (2016-01-01)